$13.40
+0.0200 (+0.149%)
At Close: Jun 03, 2026
This Women's Healthcare Stock Is Up 15% on Reports of a Takeover In the Works
09:42am, Friday, 10'th Apr 2026
Organon shares are popping Friday on signs of a takeover deal.
These Stocks Are Today's Movers: Nvidia, Intel, Lumentum, Coherent, Organon, and More.
06:26am, Friday, 10'th Apr 2026
Lumentum and Coherent were gaining on signs of strong artificial-intelligence hardware demand, while Organon was boosted by a takeover report.
Head-To-Head Analysis: XWELL (NASDAQ:XWEL) & Organon & Co. (NYSE:OGN)
01:58am, Friday, 10'th Apr 2026
XWELL (NASDAQ: XWEL - Get Free Report) and Organon and Co. (NYSE: OGN - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses base
Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
08:00am, Thursday, 09'th Apr 2026
VANCOUVER, BC / ACCESS Newswire / April 9, 2026 / (TSXV:OGN)(OTCQB:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce an update to the Mineral Reserve and Resource estimat
Organon (OGN) Stock Sinks As Market Gains: Here's Why
06:51pm, Monday, 06'th Apr 2026
In the most recent trading session, Organon (OGN) closed at $6.05, indicating a -4.87% shift from the previous trading day.
SG Americas Securities LLC Buys 117,962 Shares of Organon & Co. $OGN
04:59am, Monday, 06'th Apr 2026
SG Americas Securities LLC lifted its position in Organon and Co. (NYSE: OGN) by 74.6% during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The insti
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Monday, 30'th Mar 2026
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Organon (OGN) Suffers a Larger Drop Than the General Market: Key Insights
07:00pm, Friday, 27'th Mar 2026
In the latest trading session, Organon (OGN) closed at $5.84, marking a -3.47% move from the previous day.
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon's VTAMA (tapinarof) cream, 1% new Phase 3 pooled data analysis shows early and consistent skin clearance and itch improvements for AD patients.
Orogen Reports Record 2025 Financial Performance and Positions for Continued Growth in 2026
07:30am, Tuesday, 24'th Mar 2026
VANCOUVER, BC / ACCESS Newswire / March 24, 2026 / (TSXV:OGN)(OTCQB:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") reports preliminary and unaudited financial results for its fourth quarter
Does This $25 Million Bet on a Stock Down 61% Signal Turnaround Potential at $6?
05:22pm, Friday, 20'th Mar 2026
Sio initiated a new OGN position in the fourth quarter, buying up 3,421,765 shares. The quarter-end position value increased by $24.53 million as a result.
US FDA flags seizure risk with certain Parkinson's drugs, seeks label warnings
12:11pm, Friday, 20'th Mar 2026
The U.S. Food and Drug Administration said on Friday it has notified manufacturers of certain Parkinson's disease treatments to update their prescribing information with a new warning about a po
Organon (OGN) Falls More Steeply Than Broader Market: What Investors Need to Know
07:00pm, Wednesday, 18'th Mar 2026
Organon (OGN) closed at $6.23 in the latest trading session, marking a -2.5% move from the prior day.
Orogen Royalties Announces Private Placement Update
06:45pm, Wednesday, 18'th Mar 2026
VANCOUVER, BC / ACCESS Newswire / March 18, 2026 / (TSXV:OGN)(OTCQB:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") announces that, further to its news release dated March 12, 2026, the Compa
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know
10:01am, Tuesday, 17'th Mar 2026
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Sign In
Buy OGN